She has to know. She’s fibbing like a politician, IMO.

She can’t possibly not know what’s going on with the app. Impossible.

Very curious to see how LG’s blocker goes and the effect his trust’s unloading has on the stock, assuming they do sell around here?

Looks like Disciples are waiting for the smoke to clear so they can resume pumping.

She even denied her poor shareholders a ASM replay or transcript. They had to rely on AI Slave for it instead. 🤷‍♀️🤦‍♀️

Relax. 😂🐑

“So no to the fear mongers. We are not going to just burn through a whole bunch of shares at a crazy, fast pace.”

The elephant in the room is NICE reimbursement which you and LP breezed right over.

Why does she appear to work so hard to lose shareholders while the pump crews try so hard to maintain them, that is a real question?

Looking forward to the 2030 readout. 🙄🤷‍♀️

I think someone messed up on those units using the metric system instead of the imperial system? 😂🚀

First she’ll explain how they were able to replicate part number 3844828-4475 saving shareholders $100,000. 🤷‍♀️

Skeptics didn’t do that she torpedoed her own stock! Advent had such potential and rather than build it up she flushed it away.

Note to self: No Advent execs on the ASM call. No offer for shareholders to tour the facility.

Your read seems entirely correct now that she’s shelved Advent too.

Nem, Did you see any cracks in her performance that’d back up your allegations of NIH investigation?

Everything takes triple the time and therefor the money with this One-women-show with her “Consultant employees”. 🙄. Always been always will be.

So I ask again, with all the money that’s gone into Advent how is it possible there are no serious revenues after ten years? The equipment is now likely outdated.

Disclaimers are funny as …. You’d only make such if you were on the payroll.

It’s not the first time she’s expounded on mechanical difficulties in machines that never produce any ROI. I recall she went into a long winded explanation of something last year too, and the year before that. Shareholders could care less about day to day difficulties. It’s filler for her to make it look like she’s working hard, IMO.

Guess not. Eerie.

>> I know you disciples pretend to ignore me but surely we can all agree here?

>>Equally shocking was the lack of any kind words for Les. Wow, is all I can say.

I know you disciples pretend to ignore me but surely we can all agree here?

>>Equally shocking was the lack of any kind words for Les. Wow, is all I can say.

Just Mother Nature with no genetic engineering or anything.🤷🏻‍♂️

Without reimbursement even full UK approval wont get the stock anywhere. It’s basically Specials struggling for funding.

She actually implied answering questions at an ASM is uncommon while also never holding quarterly calls. That’s the women’s true character! A real retail clubbing.

LP gets off on describing equipment and difficulties for some reason. She probably thinks it conveys a getting her hands dirty image?

Even Danish has to be wondering what the heck’s going on?

And not even a mention of Advent’s potential. It’s going to ten cents.

This line is so funny it makes me cry. What’s she saying exactly? I think she’s saying don’t worry we won’t use it all up in six months but it could take two years. LOL. And she seems confident the stock can hold here even though she never mentions ROI. Just crazy stuff.

>>Let me put it in perspective. Our burn rate in 2023 and 2024 was particularly high, very intensive years, in the low 50 millions. It’s down substantially this year. But if we kept up that same burn rate, and we did all equity financing, and the price was still in the 24, 25 cent range, it would take years to use those shares.

And we’re not going to do all equity financing, and we certainly hope that our share price is not going to stay at 24, 25 cents. We plan to focus on non-dilutive.

So no to the fear mongerers. We are not going to just burn through a whole bunch of shares at a crazy, fast pace.

😂😂. Also she loves “Laser focused” using for going on a decade.

Everyone here already did their dd on that a year plus ago and came up empty. Also consider the large majority of biotechs / pharma submit to the FDA or EMA first, so MHRA pushes them right through. She’s talking out her —-

She always did that. Nerves. She doesn’t do public appearances. Even audio is rough for her. Did you notice how she emphasized the risks or how she has no intention of holding quarterly calls? And did you notice how she said most companies don’t do questions on a ASM like she was doing everyone a favor? Still you see no red flags. Got it.

>>Genuine question: Why was she giggling at times when there was nothing humorous in the topics being discussed?"
I'm not sure. I paid attention more to her tone . The tone was full of positive waves from what I could hear. I didn't like her skirting around MHRA question but giving us 2nd hand info like "people who are close to MHRA say they are amazed at the help they have given us" or something to that effect. She didn't sound like she was trying to sell us something, more like she knew good info and was looking forward to the coming months. Maybe I was reading too much into it.

With no mention of Advent revs and no discussion of ROI, and just more early trials, this one is heading to ten cents within a week, IMO.

The “army of consultants” is here with us, IMO.

Yep.

Did you happen to notice dying patients or pediatrics weren’t mentioned once?

See SteadyT obfuscate. We weren’t talking about NWBO we were talking about other biotechs she says are in the same boat, but you knew that.

Don’t be so gullible. Do you really think the FDA would approve L’s MAA before they had a chance to study years of real world evidence paid for by the UK?

It is a joke. She just throws stuff out there every year with no means to pay for any of it except at 25 cents or much less, or free. Same as it ever was.

Shocking the lack of detail on Advent. Now I think you’re right, she just transferred the shell.

Equally shocking was the lack of any kind words for Les. Wow, is all I can say.

In other words “OK, Later shareholders, we’ll talk sometime in 2027”. Got it. What a joke. Same old walk up a down escalator.

>>but I think it gives you a pretty exhaustive understanding of where we are, both where we are now and where we’re planning to go in the coming calendar quarters.

So no interviews just hire the consultants if things work out. Got it. How incredibly lazy…and expensive.

>>The expansion of the management team is a very high priority for the management team. We would really like to have more of us. And what I am really happy to be able to tell you is the first wave of that management team expansion is already ready.

We already have senior managers who have been working with us for anywhere from six months to several years in positions technically as consultants, and when and if we receive an approval, they will just step seamlessly into doing the same role, but as an employee of Northwest.

And the personnel that we have who have been working in these consulting capacities are in the clinical, medical area, finance, accounting, and operations. So each one of the major areas. So that right there is already the first immediate expansion of the management team, and we have more on our radar screen, and that of course includes succession aspects.

But she can’t assign a value to it, of course. Some very happy lawyers I bet though.

>>And we’ve worked hard, and we spent a lot of money to file our patents and prosecute them and maintain them in all these various countries so that we would have the ability to do these kind of deals. And that was a lot of money. We spend well over a million dollars, approaching one and a half million dollars a year, on patent costs alone. We have a large patent portfolio.

Ahahahahahaha! Sure LP. Well hear from you again in a year and a half or so.

>>Now it’s really important I want to address the fear mongering that I believe has gone on a bit about, oh my goodness, they’re just going to willy nilly issue 900 million shares in the next two weeks, or in a crazy short period of time. No. We’re definitely not going to do it.

Let me put it in perspective. Our burn rate in 2023 and 2024 was particularly high, very intensive years, in the low 50 millions. It’s down substantially this year. But if we kept up that same burn rate, and we did all equity financing, and the price was still in the 24, 25 cent range, it would take years to use those shares.

And we’re not going to do all equity financing, and we certainly hope that our share price is not going to stay at 24, 25 cents. We plan to focus on non-dilutive.

So no to the fear mongerers. We are not going to just burn through a whole bunch of shares at a crazy, fast pace.